Teleflex | TFX - Current Assets


Teleflex reported $1.94B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Align Technology USD 2.66B 38.87M Mar/2026
AngioDynamics USD 161.35M 4.69M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Avanos Medical USD 355.4M 4M Dec/2025
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.68B 110M Mar/2026
Cooper Companies USD 2.13B 27.4M Dec/2025
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.74B 380M Dec/2025
General Electric Aerospace USD 40.36B 235M Mar/2026
Globus Medical USD 2.13B 201.25M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intuitive Surgical USD 11.52B 881.5M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Masimo USD 926M 122.3M Dec/2025
Medtronic USD 24.07B 75M Dec/2025
Merit Medical Systems USD 1.1B 61.62M Mar/2026
Orthofix International USD 416.85M 22.68M Dec/2025
ResMed USD 4.06B 245.26M Mar/2026
Steris USD 2.29B 179.9M Dec/2025
Stryker USD 13.34B 1.42B Mar/2026
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.94B 47.65M Dec/2025
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026